Kristen Marks is an Infectious Disease physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
525 E 68th St Ste J314
New York, NY 100214870
Telephone
212-746-2225Registry record last updated 27 Mar 2013.
Clinical trials
- B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- HCV Seek, Test and Rapid Treatment for Young PWID
Sponsor: Weill Medical College of Cornell University
- Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID)
Sponsor: City University of New York, School of Public Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20232 payments
- Janssen Scientific Affairs, LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2005–2020 per NIH RePORTER. The latest:
- Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care
Graduate School of Public Health and Health Policy
FY2020$534,162R01DA041298 - Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care
Graduate School of Public Health and Health Policy
FY2019$554,667R01DA041298 - Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care
National Development and Research Institutes, Inc.
FY2018$557,431R01DA041298
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”